Additionally, HKDC1 serves as a prognostic indicator, with higher levels associated with poor outcomes and overall survival in cancers such as colorectal and lung squamous cell carcinoma, influencing tumor-immune interactions and aiding in personalized therapeutic strategies. This evidence concerns the gene HKDC1 and squamous cell lung carcinoma.